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Abbreviations 

CPZ chlorpromazine  
CMC Critical micellar concentration 
DOPet 1,2-dioleyl-sn-glycero-3-phosphoethanol  
DOPmet 1,2-dioleyl-sn-glycero-3-phosphomethanol  
DPPC 1,2-di-palmitoyl-sn-glycero-3-phosphocholine
DPPN 1,2-dipalmitoyl-sn-glycero-3-phospho[N-(4-nitrobenz-2-oxa-1,3-diazolyl)]­
ethanolamine
EDTA ethylenediaminetetraacetic acid
egg-PA egg yolk phosphatidic acid
LUV Large unilamellar vesicle
Lyso-PA 1-stearoyl-2-hydroxy-sn-glycero-3-phosphate 
Lyso-PG  1-stearoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] 
M-1 (2S,3R)-2,3-dimethoxy-1,4-bis(N-hexadecyl-N,N-dimethylammonium)-butane 
dibromide 
MLV Multilamellar vesicle
NMR Nuclear magnetic resonance spectroscopy 
POPA palmitoyl-oleyl-sn-glycero-phosphatidic acid
POPC 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
POPE 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphoethanolamine 
POPG 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol  
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine) 
POPI 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol  
PPDPC 1-Palmitoyl-2[10-(pyren-1-yl)]decanoyl-sn-glycero-3-phosphocholine  
SRM siramesine ((1'-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]-1-butyl]spiro[isobenzofuran­
1(3H),4'-piperidine]) 
T Temperature
Tp Pretransition temperature
Tm Main phase transition temperature
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1 Abstract 
Cells are packed with membrane structures, defining the inside and outside, and the different 
subcellular compartments. These membranes consisting mainly of phospholipids have a variety of 
functions in addition to providing a permeability barrier for various compounds. These functions
involve cellular signaling, where lipids can act as second messengers, or direct regulation of
membrane associating proteins.  
The first part of this study focuses on relating some of the physicochemical properties of 
membrane lipids to the association of drug compounds to membranes. In brief, a fluorescence
quenching based method is described allowing for convenient determination of the membrane
association of drugs. This method was subsequently applied to a novel drug, siramesine, previously
shown to have anti-cancer activity. Siramesine was found to associate with anionic lipids.
Especially interesting is its strong affinity for a second messenger lipid phosphatidic acid, with a
partition coefficient of an order of magnitude larger than for other anionic or uncharged lipids.
This is the first example of a small molecule drug compound specifically interacting with a cellular
lipid. Phosphatidic acid in cells is required for the activation of many signaling pathways mediating
growth and proliferation. This provides an intriguing possibility for a simple molecular
mechanism of the observed anti-cancer activity of siramesine.
In the second part the thermal behavior and self assembly of charged and uncharged membrane
assemblies was studied. Strong inter-lamellar co-operativity was observed for multilamellar DPPC
vesicles using fluorescence techniques together with calorimetry. The commonly used membrane
models, large unilamellar vesicles (LUV) and multilamellar vesicles (MLV), were found to possess
different biophysical properties as the lamellae of MLVs strongly interact with each other, also
driving the segregation of the pyrene labeled lipid analogue into clusters. The effect of a counter-
ion lattice on the self assembly of cationic gemini surfactant was studied. The presence of NaCl 
strongly influenced the thermal phase behavior of M-1 vesicles, causing the spontaneous formation
of giant vesicles with 30-50 μm diameter upon exceeding a certain phase transition temperature, 
followed by a subsequent transition into a more homogenous solution of more uniform vesicles
with a smaller diameter in the range of 15 μm.
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Understanding the underlying biophysical aspects of cellular membranes is of fundamental
importance as the complex picture of the structure and function of cells is evolving. Many of the
cellular reactions take place on membranes and membranes are known to regulate the activity of
many peripheral and intergral membrane associating proteins. From the point of view of drug
design and gene technology, membranes can provide an interesting target for future development 
of drugs, but also a vehicle sensitive for environmental changes allowing for encapsulating drugs
and targeting them to the desired site of action.
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2 Review of the literature 
2.1 Lipids 
The main focus in the research of biological molecules was for a long time on the macromolecules
proteins and nucleic acids. Watson & Crick described the structure of the DNA double helix as
early as 1953 (Watson and Crick 1953). The earliest studies on protein structure and function date 
to 1926 when the enzyme urease was recognized to be a protein (Sumner 1926). Today the
structure and material properties of a vast number of proteins are well established. From the major
groups of biological molecules carbohydrates and lipids (Fig. 1) have received less attention. This 
relates partly to the complex chemistry involved and on the other hand to the special techniques
required in studying these compounds. The bilayer structure of the cellular plasma membrane of
red blood cells was established already in 1925 (Gorter and Grendel 1925) and some experimental 
techniques such as assessing surface tension date back to 1863 (Wilhelmy 1863). When Singer and
Nicholson presented their fluid mosaic model of the cellular membrane in 1972 they 
revolutionized the field of lipid research (Singer and Nicolson 1972). Since those times the 
development of e.g. sensitive fluorescence techniques (Kinnunen et al. 1993), electron microscopic 
techniques together with high resolution NMR (Schiller et al. 2007) and X-ray techniques (Cevc 
1991; Loebbecke and Cevc 1995) has allowed for the picture of the cellular membrane to evolve
into a more specific understanding of their structure and function. They are now thought not only
to serve as a solvent matrix for membrane
associating proteins but also as a highly
versatile and dynamic structure controlling 
cellular behavior (Mouritsen and Kinnunen
1996; Mouritsen 2004).  
In this thesis I focus on the biophysical 
characterization of various phospholipid
model membrane assemblies together with
the role of phospholipids in the binding of
drugs to liposomes.
10 
Fig. 1 An eukaryote cell is full of membranes, mainly 
consisting of phospholipids. 
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2.1.1 Lipids as structural components of cellular membranes
Lipids are the main constituents of cellular membranes. There are more than 1000 different lipid 
species in the different membranes of a eukaryote cell (Kinnunen 1991). Taking into consideration 
chemically modified lipids such as peroxidated lipids the number increases severalfold (Seppänen-
Laakso and Oresic 2009). The main classes are glycerophospholipids, which generally have 2 fatty­
acyl chains covalently attached to a glycerol backbone (Fig. 2). On the third carbon there is a 
phosphate group, which often carries a hydrophilic head-group, thus making the molecule
amphiphilic. Sphingolipids and cholesterol are the other major lipid families present in eukaryotes.
In addition to lipids eukaryote membranes contain transmembrane and peripheral membrane
associating proteins (Gennis 1989). 
Different membranes form diffusion barriers dividing 
cells into compartments, such ascellular organelles e.g. 
mitochondria, lysosomes, the Golgi apparatus and the 
endoplasmic reticulum. Membranes form permeability 
barriers between cellular components allowing for 
different chemical properties on the opposing sides of a 
membrane. This is of fundamental importance for the 
proper functioning of cells. The different chemical 
compositions of the inside and outside of cells
maintain the osmotic balance, keeping the cells from 
rupturing. The unequal distribution of ions over 
membranes is actively maintained and is one of the 
most energy consuming processes in the human body. 
On the other hand chemical gradients over membranes 
are crucial also in the production of energy in the form 
Fig. 2 The chemical structure of a of ATP on the inner mitochondrial membrane (Nelson 
glycerophospholipid POPC
and Cox 2009). Also many chemical reactions 
1. The choline head-group 
involving membrane associating enzymes or lipids take 2. Phosphate group 
place on the membrane surface. This limits the volume 3. Glycerol backbone 
4. SN-1 acyl chain 
in which the reactions happen increasing the 5. SN-2 acyl chain 
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probability of molecules meeting each other as their mobility is limited to movements in 2 
dimensions. 
Cellular lipids have different chemical properties. Such differences can concern the hydrophilic 
head-group region where parameters such as headgroup size, shape or charge affect the molecule,
or they can involve the hydrophobic hydrocarbon region of the lipid with parameters such as the
length and amount of double bonds within the hydrocarbon (Lehtonen and Kinnunen 1995b) and
the number of acyl chains. Such parameters determine the effective shape and overall properties of 
a given membrane (Kinnunen 1996). Cholesterol is a special lipid, structurally very different from
the previously discussed glycerophospholipids and sphingolipids. It has an iso-octyl hydrophobic 
tail, connected to a stiff aromatic ring structure. Cholesterol has  a very small headgroup
comprising of an OH-group on the head. These structural properties give cholesterol a role in
regulating the stiffness and shape of biological membranes (Yeagle 2005). 
2.1.2 Water as a biological solvent 
Most of the chemical reactions occurring in cells take place in an aqueous environment. Water is
an abundant component of all living organisms, comprising more than 70% of the weight of living 
organisms (Ling 2004). Water is a small molecule and has some unique solvent properties making 
it a suitable medium for living organisms. These properties owe to the polarity of the H2O 
molecule, its high dielectric constant of 78.5, together with its strong tendency to form hydrogen 
bonds, leading to high melting and boiling temperatures. The structure of crystal water (ice) is a 
highly organized hydrogen bonding network. Even for liquid water hydrogen bonding remains 
important giving rise to its unique solvent properties as it favours interactions of water with other
polar molecules. Nonpolar molecules tend to interact with each other, to minimize the free energy 
penalty caused by the disturbing effect on the hydrogen bond network of water, thus being poorly
soluble. Substances poorly soluble in water such as lipids, waxes and oils are referred to as 
hydrophobic, whereas polar well soluble compounds that ‘prefer’ being dissolved in water are
hydrophilic. Many small compounds and biological molecules exhibit both hydrophilic and
hydrophobic properties e.g. at the different ends of a phospholipid molecule, such compounds are 
amphiphilic in nature. When hydrophobic compounds are introduced to an aqueous environment
the regular hydrogen bonding network is disturbed and this leads to an increase in the free energy 
12 

   
 
 
 
 
 
 
  
 
  
  
 
 
 
 
  
2.1 Lipids 

of the system. Minimizing this free energy gives origin to the so-called hydrophobic effect, trying 
to minimize the contacts of the hydrophobic molecules with water. This is the main driving force
for the self assembly of lipids into bilayer structures and also to a large extent for the proper folding
of proteins.
Solubility alone does not, however, describe the complex interactions of biological molecules with
water in a sufficient manner. The hydration shell of a molecule consists of the H2O molecules that 
are in close contact to the solute differing in orientation and hydrogen bonding profile as 
compared to the bulk ‘free’ water in the solution (Gawrisch et al. 1992). These molecules are, 
however, not tightly bound to the solute but continuous molecular exchange occurs. The level of
the hydration relates to the osmotic pressure caused by the solute and is in the case of 
phospholipids mainly affected by the headgroup size and charge (Israelachvili and Wennerström
1996). 
2.1.3 Critical micellar concentration CMC
The solubility of lipids in water is poor. However, amphiphilic molecules due to the hydrophobic 
effect spontaneously form ordered soluble aggregates in an aqueous solution. The critical micellar
concentration is defined as the concentration above which amphiphiles added to solution
participate in aggregate formation rather than existing as free monomers  in solution. For the  
phospholipids we have used in the work this thesis is based on, the CMC  is roughly of a nM range. 
CMC can be determined from the Gibbs free energy isotherm from a dilution series, as surface
tension is dependent on the logarithm of the dissolved monomer concentration of the surface
active compound and thus remains constant after reaching CMC. 
13 
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2.1.4 On the organization of lipids 
In an aqueous environment lipids self-assemble into different structures depending on their 
chemical and biophysical properties. These structures such as micelles, vesicles or bilayers form in
order to minimize the free-energy of the system, that is, to hide the hydrophobic hydrocarbon 
regions away from the water molecules. This self-assembly is mainly driven by the hydrophobic 
effect. The main factor determining the shape of the forming aggregate is the effective shape of the
amphiphile. The effective shape is determined by molecular properties, such as the van der Waals
volume of the molecule, the headgroup hydration shell, intra- and inter molecular hydrogen
bonding and the length and grade of saturation of the acyl chains. In order to predict and describe
the effect of change in molecular shape on the organization of the lipids the concept of packing
parameter (p) has been defined as (Israelachvili et al. 1980) 
eq 1
ݒ݌ ൌ ܽ ൈ
Where v represents the effective volume of the hydrophobic part of the molecule, a stands for the
limiting area of the hydrophilic headgroup, and l is the length of the hydrophilic part (Fig. 3).
Lipids with p ≈ 1 tend to form lamellar bilayer structures, whereas values for p > 1 correspond to a 
cone molecular shape () where the hydrocarbon volume is large compared to the headgroup 
 ݈
Fig. 3 The packing parameter p describes the relation of the volumes of the hydrophobic and hydrophilic parts
of the lipid molecule, thus defining the effective molecular shape. The figure was kindly provided by MD, PhD
Samppa Ryhänen.
14 
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leading to the tendency of forming inverted phases. Values for p < 1 mean that the molecule is 
more inverted cone shaped () leading to the formation of micellar structures (Kinnunen 1996; 
Mouritsen 2004).  
In a biological membrane consisting of different lipids and lipid species the shape of the individual
lipid molecules contribute to the overall shape of the membrane. In other words the membrane is 
curved due to the spontaneous curvature of its constituents. Membrane spontaneous curvature can 
be negative or positive depending on the magnitude of p of the individual components.
Cholesterol, having a small headgroup and a large, stiff hydrophobic part with a high negative 
spontaneous curvature of its own, introduces also negative curvature into the membrane
(Churchward et al. 2008). This also allows for a regulational mechansim. If the lipids in a 
membrane are chemically modified, for example if the head-group or a hydrocarbon tail (Fuller
and Rand 2001) of a lipid is cleaved, the p value of the given lipid is modified, thus also altering the
overall curvature in the membrane. Typical examples involve formation of ceramide from
sphingomyelin (Holopainen et al. 2000) or the formation of diacylglycerol from
glycerophospholipids (Szule 2002) as discussed in more detail below.  
Biologically the most important structures formed by lipids are lamellar bilayer structures in which
two lipid leaflets form a double layer in which the hydrophobic parts are facing each other and the
polar hydrophilic head groups point 
outwards to the aqueous solvent. Given 
the fact that bilayers are kept together 
by non-covalent bonding of molecules, 
they are highly dynamic structures.
From a physical point of view lipid
membranes are referred to as soft
matter. In addition to the constant
intramolecular movements of the
hydrophobic acyl chains and the 
headgroup happening on a picosecond
(10-12 s ) scale, a lipid molecule in a 
bilayer can move around in several 
ways, on different time and length 
Fig. 4 A schematic representation of the cellular plasma 
membrane with laterally organized lipid domains together 
with membrane associated proteins and carbohydrates.
Image kindly provided by prof. Kinnunen 
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scales (Yeagle 2005). Lipids can normally freely rotate around their own axis, typically requiring a
few nanoseconds to occur. In the same time lipids can laterally diffuse over a range of their own
diameter. On a larger scale bilayer lipids can diffuse laterally within their respective membrane
leaflet, typically requiring a time of ~30 seconds for traveling across a typical cell membrane. Also
trans-bilayer movements called flip-flop occur (McConnell and Kornberg 1971; Nakano et al. 
2009). These however are much slower processes as compared to lateral diffusion taking hours or
even days to occur for a given lipid molecule. This timescale is such that in a biological system for
it to be under control a specific enzyme is required to catalyze flip-flop reactions.(Dolis et al. 1997) 
Singer and Nicholson presented their fundamental fluid mosaic model of the cellular membrane in 
1972 (Singer and Nicolson 1972). This model is more a description of the organization of the lipids
as bilayers than an actual physical model, being able to predict the behavior lipid assemblies. The 
fluid mosaic model assumes random distribution of the lipids in the plane of the membrane.
Membrane associated proteins float in an unorganized ‘sea’ of lipids. Later this model has evolved 
in several aspects (Fig. 4). It has become evident that the lateral organization of lipids is not
random but lipids rather form clusters or microdomains. These microdomains introduce localized 
areas differing from the bulk membrane not only in lipid composition but in properties such as 
charge density or curvature. Such local curvature changes are balanced by introducing lipids with
opposite curvature effects to balance out the free energy stress (Sheetz et al. 1976).  A special case 
of micro domains are sphingolipid and cholesterol rich domains, described in the early 1980’s 
(Luan et al. 1995; Pessin and Glaser 1980) and recently commonly referred to as lipid rafts (Simons 
and Ikonen 1997).  Also the lipid composition of the membrane leaflets is strictly regulated. The 
best known example is the localization of phosphatidylserine in the inner leaflet of the plasma
membrane. Even the surroundings of a given membrane protein are regulated. It has been shown 
that membrane proteins can have specific binding sites for certain phospholipids whereas other 
proteins require lipids as cofactors for their activity. 
2.1.5 Lateral pressure, membrane electrostatics 
Because of the fact that lipids spontaneously form bilayers to minimize the exposure of the 

hydrophobic core to water, tension exists within a membrane. This is referred to as lateral 

pressure. (Isrealeachvili 1991) The overall pressure profile over the membrane sums zero, since the
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membrane does not expand or shrink due to these forces. However, within the membrane
considerable lateral pressure exists. It is mainly constituted by two opposite forces, namely the
repulsion forces between the nearby head-group and that between the acyl chains, defined by the
packing density of the membrane, opposed by the interfacial tension deriving from minimizing the 
contacts of the acyl chains with water and keeping the structure together (Fig. 5). For biological 
membranes the packing density leads to the repulsive component of the pressure profile
corresponding to a monolayer equivalent lateral pressure of approx. 30-35 mN/m (Kinnunen 2000;
Marsh 1996). Further the lateral pressure profile gets varying contributions from the different parts 
in the membrane depending on the effective shape of the lipids and other constituents of the
membrane (Cantor 1999a). 
The role of lateral pressure on the
function of membrane embedded
proteins has been discussed ( Cantor
1997; Cantor 1998; Cantor 1999b;
Cantor 1999c;). It has been proposed
that by altering the pressure within
the membrane proteins such as ion 
channels may adopt a different
conformation thus regulating the flux 
of ions and other solutes (Marsh
2007). This would be a mechanism
not directly involving binding of 
substances to specific binding sites on
proteins. The problem, however, is 
that there are no means to measure
the lateral pressure, or changes in it.
Recently, the problem has been
addressed by molecular dynamics 
(MD) simulations allowing for
mathematical modeling of the lateral
pressure profile and solute effects to it
(Griepernau and Boeckmann 2008;
Fig. 5 A schematic representation of the lateral pressure
profile and the factors contributing to it. Image reproduced
with permission from Alakoskela et al. 2009 
17 
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Terämä et al. 2008). Drugs binding to lipid bilayers have a certain size and shape and based on the 
information gathered on the localization of a drug in the membrane it is possible to anticipate how
the lateral pressure is likely to be affected in different parts of the membrane. In a lipid monolayer
interfacial tension can be directly monitored using microbalances and data from such experiments
can aid the interpretation of the events taking place in a bilayer (Brockman 1999).
Over a lipid bilayer there is an electric potential caused by the different chemical composition of 
the medium on the opposing sides (Brockman 1994). This is especially true for charged lipids, 
where the head-group charges and the associated counter ion lattice affect the electric charge 
distribution in the vicinity of the membrane. If considered more carefully the electric potential of a 
membrane can be subdivided into surface potential, due to the surface charge of the head-group
and the closely associated counter-ions, dipole potential, related to the orientation of the head-
group dipole of the phospholipids and trans-membrane potential corresponding to the potential
differences in the bulk solutions on the opposing sides of the membrane (Cafiso 1998). 
2.1.6 Phases and transitions  
Matter exists in different forms or phases. Water for example commonly exists as a liquid, as a
solid and as gas. Changes in the state of matter are referred to as phase transitions (Papon et al.
2002). Liquid crystals, such as phospholipids undergo a variety of temperature dependent
transitions (Kinnunen et al. 2003; Kinnunen et al. 1991). Dipalmitoyl-sn-glycero-3­
phosphocholine (DPPC) has been commonly employed as a model phospholipid in phase 
transition studies (Mouritsen 1991). Upon heating a sequence of three transitions can be observed 
for this lipid: a subtransition from the crystalline (Lc) to the gel (Lβ') phase, a pretransition from gel
(Lβ') to the ripple (Pβ') phase, and the main transition from the ripple (Pβ') to the liquid-crystalline
(Lα) phase (Alakoskela and Kinnunen 2004; Rappolt et al. 2000). For a given transition the
temperature at which half the transition is completed is defined as the corresponding transition
temperature e.g. Tp for the pretransition and Tm for the main phase transition. The subtransition 
corresponds to loss of order of the headgroup lattice, and the two latter correspond to phenomena 
closely connected to acyl chain melting (Heimburg 2000). The pretransition at Tp typically 
precedes the main transition at Tm by a few degrees, this difference decreasing with increasing 
length of acyl chains and decreasing hydration of phospholipids (Cevc 1991). Substitutional
18 
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impurities added to membranes (Prenner et al. 1999) affect the pretransition, commonly 
decreasing its amplitude and broadening the peak in heat capacity traces. However, also under
these conditions the pretransition may remain distinguishable by other methods 
(Mavromoustakos et al. 1997). 
The phase transition temperatures depend on a variety of factors and get contribution from the 
lipid headgroup, grade of saturation, charge, possible hydrogen bonding etc. (Cevc et al. 1981). In 
humans the phase transition temperature of the cellular plasma membranes lies close to 37
degrees, so that the plasma membrane stays fluid at most occasions. However, it has been
suggested that phase transitions are involved the conduction of nerve impulses in axons, as a
propagating fluid-gel-fluid phase transition wave (Kinnunen and Virtanen 1986).
2.1.7 Charged lipids 
Phospholipids generally carry one or multiple charges on their head-groups.  A negative charge is 
provided by the phosphate group linking the head group and the glycerol backbone. The 
remaining head group often carries a positive charge leading to the phospholipid to become
zwitterionic. At pH 7 such zwitterionic lipids are usually neutral. In the literature the discussion on 
charged lipids usually refers to lipid carrying a net charge at neutral pH, i.e. zwitterionic lipids are
considered uncharged. Having a net charge in the head group affects multiple properties of the 
lipid molecule, such as the hydration and thermodynamic behavior of the membrane as well as the
counter-ion lattice in the immediate surroundings of the membrane (Cevc 1990). 
The anionic lipids used in this study lack the positive charge of the head group. The most common
anionic lipids appearing in eukaryotes carry one negative charge i.e. are monoanionic. The most
important anionic lipids are phosphatidylserines, phosphatidylglycerols, phosphatidylinositols and
phosphatidic acid. Incorporating anionic lipids into phospholipid vesicles attracts counter-ions
towards the membrane surface in a manner rather accurately described by the Gouy-Chapman 
theory (Gouy, 1910; Chapman 1913; for recent review see Henderson and Boda 2009). In addition,
anionic lipids also attract protons creating a local low pH environment in the vicinity of the
membrane, even though the buffered aqueous bulk pH remains unaltered. For a membrane 
19 
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containing 20% PS the surface pH has been calculated to be in the range of 5.2 to 5.5 (Gorbenko et
al. 2006). 
Phosphatidylserine (PS) has been of special interest since it is the most abundant charged lipid in 
eukaryote cells covering up to 20% of the total phospholipid content of the plasma membrane. It
generally resides on the inner leaflet of the plasma membrane, as there is a specific carrier protein 
aminophospholipid translocase (APTL) actively maintaining the asymmetrical distribution of this 
lipid (Dolis et al. 1997). Loss of the asymmetric distribution of PS  is a key feature of early 
apoptotic cells (Fadok et al. 1992) and can be used in staining techniques to distinguish apoptotic 
cells from healthy cells by Annexin V (Vermes et al. 1995). This concept was developed further and
also synthetic cationic lipids (Bose et al. 2004) can be used to identify apoptotic cells. Cancer cells 
also present phosphatidylserine on their outer membrane leaflet (Zwaal et al. 2005), and it has been 
proposed that the interaction of cancer cells with a natural antimicrobial peptide endostatin is due 
to its binding to PS (Zhao et al. 2005). Furthermore, PS has a special role in the activation of the 
thrombotic pathway, possibly also involved in the thrombophilia associated with various types of
cancer. PS also promotes the binding of several cationic amphiphilic drugs (CADs) to membranes
(Takegami et al. 2005) and has also been linked with the formation of fibrillous protein aggregates 
(Alakoskela et al. 2006). 
Phosphatidic acid (PA) is a lipid, which has a very small head-group, only the phosphate in the sn­
3 position of the glycerol backbone. This gives PA a special shape, where the hydrophobic region 
has a very large volume as compared to the hydrophilic part. This property introduces negative 
curvature in the membranes and drives the formation of non-lamellar phases in PA containing
vesicles (Kooijman et al. 2005). Such behavior is important as the formation of PA is involved in 
processes requiring membrane fusion (Holopainen et al. 1999). PA carries a net negative charge of 
1 at physiological pH, although it has been proposed that upon hydrogen bond formation PA
becomes deprotonated to form a divalent anion (Kooijman et al. 2007). The special role of PA in 
cell signaling is discussed below.
Naturally occurring cationic lipids are rare. Sphingosine, a cationic sphingolipid is present in the 
nuclear membranes of eukaryotes has been shown to interact with DNA (Kôiv et al. 1995). 
Sphingosine also affects the head-group dipole orientation of POPC in mixed monolayers (Säily et
al. 2001). The other naturally occurring cationic lipid is the so called ‘sleep inducing lipid’ 
oleamide originally isolated from the spinal fluid of sleep deprived cats (Cravatt et al. 1995).
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Synthetic cationic lipids, however, are widely used as detergents and soaps even to the extent that
on an industrial scale their waste has caused problems for river navigation (Yapijakis and Wang
2006). Lately, cationic lipids have been a promising vector for gene transfer (Ryhänen et al. 2003),
due to their strong interactions with DNA together with their ability to penetrate cells without 
killing them. This has lead to also compounds being commercially available for this purpose. 
Gemini surfactants are a special group of synthetic lipids consisting of two usually identical 
surfactant molecules connected by a hydrocarbon spacer (Menger and Littau 1991).  
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2.2 Lipids in health and disease 
In addition to the more biophysical properties of lipids addressed so far, lipids also serve in a 
variety of physiological and pathological functions. The traditional approach to studying and
treating pathological conditions has been to try to identify the malfunctioning proteins and to
subsequently pharmacologically alter their functions to get the desired effect. Lipids are known to 
be involved in a variety of pathological conditions. Recent technological advances in the field of
mass spectroscopy has allowed for the lipidomic characterization of tissues in various pathological 
conditions (Bougnoux et al. 2008; Graessler et al. 2009; Postle 2009). Below some of these aspects 
are more carefully discussed. 
2.2.1 Lipids as signaling molecules 
Cells utilize multiple pathways of signal transduction in translating the response to external stimuli 
to changes in cellular functions. One mode of action is that binding of a ligand to a receptor on the 
cell surface activates phosphorylation cascades which turn on or off different cellular functions.
Lipids are also involved in these processes. In order to amplify and transmit the signal from the
external source among the first steps after activation of a cell surface receptor is the production of a
second messenger. Such second messengers are for example cyclic AMP or cAMP, but also the 
lipids phosphatidic acid (PA), diacylglycerol (DAG) (Goni and Alonso 1999),
phosphatidylinositols and sphingolipid derivatives such as ceramide, sphingosine, and
sphingosine-1-phosphate. This makes sense, since on the membrane lipids are readily available
and they can be activated as signaling molecules by means of simple chemical modifications.
PA is produced in a variety of cells in response to growth stimuli. A number of proteins promoting 
cell survival such as Hsp (Chowdary 2007), mTOR (Hornberger et al. 2006), Raf (Ghosh et al.
1996), Ras (Andresen 2002), and Sos (Zhao 2007), require PA for their activity. Yet, it is crucial 
also in the activation of RAS and TNF-α mediated apoptosis (Hancock 2007). PA may further be 
involved in the pathogenesis of systemic vasculitis (Williams 2007). The major pathway producing
PA in vitro involves phospholipase D, which cleaves the headgroup of either PE or PC to yield PA.
Other pathways producing PA in cells involve acylating lyso-PA by lyso-PA acyl transferase (La
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Rosee et al. 2006) and phosphorylation of diglyceride by diglyceride kinase (Sakane et al. 2007).
Different cancer cell lines utilize distinct pathways to generate PA allowing them to escape
apoptosis (Steed and Chow 2001), and also exogenous PA has been shown to act as an anti­
apoptotic signal. Consequently, there is an intense search for PLD inhibitors that could be used as
anticancer drugs to decrease the levels of cellular PA (Foster 2006). Rapamysin is a 
chemotherapeutic compound targeting the mTOR protein. Rapamysin is a competitive inhibitor of 
PA binding to this protein (Foster 2007; Toschi et al. 2009).  
Ceramide is a lipid also produced by chemical modifications of the membrane. Sphingomyelinases 
cleave the headgroup of sphingomyelin to yield ceramide. The role of ceramide on the membrane
differs from PA in rather than being growth promoting, it induces apoptosis, programmed cell
death, in cells. Another role of ceramide is to induce negative curvature to the membrane 
(Holopainen et al. 2000; Nurminen et al. 2002). This might be involved in endocytosis and vesicle
formation within cells. Interestingly, sphingosine-1-phosphate, readily interconvertable with 
ceramide acts as a growth promoting signal. Thus the balance between these is carefully 
maintained. 
In addition to intracellular signaling, organisms utilize lipids in a variety of other signaling
functions. Steroid hormones are an example of endocrine lipid signaling, eicosanoids such as
prostaglandins are important paracrine regulators of cellular functions as well as mediators for
inflammation. 
Oxidative stress introduces reactive oxygen species especially in mitochondria. This among other
things leads to the peroxidation of lipids. The role of oxidized lipids in various pathological 
conditions is under intensive study. Until now lipid oxidation has been especially considered in the 
context of atherosclerosis, where the oxidization of LDL particles in the arterial endothelium
causes a series of events finally leading to plaque formation, and calcification (Berliner et al. 2001). 
Recently, however, oxidized phospholipids have been identified as potential binding sites for some
drugs (Mattila et al. 2008b; Mattila et al. 2007), as well as promoting the association of peripheral 
membrane proteins (Mattila et al. 2008a). 
The development of powerful, high throughput mass spectroscopy techniques has given insight to 
the lipid composition of various tissues in different states and under various pathological
conditions (Postle 2009).
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2.3 Why study drug lipid interactions? 
2.3.1 Drugs in the context of lipids
The pharmaceutical industry is in continuous search for new biologically active compounds to be
used as drugs. The traditional approach has been isolating natural compounds and testing them on
cell based models. The development of molecular biology techniques has allowed for the 
identification of the drug targets and specifically screening large compound libraries for favourable
interactions. So far these drug targets have been almost exclusively limited to proteins (Rang et al.
1999). After a suitable compound has been identified it still needs to go through a vast screen of 
testing to become a commercially available drug. The main concerns are the drug’s absorption,
distribution, metabolism and excretion, together with the compound’s possible toxicity commonly 
referred to as the ADME/tox profile. A compound effectively binding its target can have such
biophysical properties, that it is not absorbed from the intestine, or that it otherwise never reaches
its target in the organism (Lipinski 2000; Lipisnki and Hopkins 2004). Also many drugs that bind
to the same receptor protein differ in their side effects. Such undesired side effects are often poorly
understood and the underlying causes are complex. Predicting prior to clinical testing would be of
fundamental importance for the development of novel drug compounds. 
Many drugs are amphiphilic and thus readily bind to phospholipid membranes. A widely used
prediction for the membrane association of a given drug has been defining the logP value for a 
compound. That is the logarithm of the bulk octanol/water partitioning coefficient of an 
uncharged drug compound (Lipinski 1997). These values can be relatively easily predicted by 
computation, which makes the approach convenient. Phospholipid membranes, being a highly 
anisotropic environment, however, differ in several critical aspects from bulk octanol as discussed
in more detail above, making log P a relatively poor predictor of the membrane association of
drugs. The interactions of drugs with membranes are often of nonspecific nature, as drugs rarely
form an 1:1 stoichiometric complex with phospholipids. Thus the binding is dependent of the
concentrations of the lipid and the drug. More specifically, the amount of membrane associated
௅ሾܦൌ௣ܭ ሾܮሿ 
drugs can be determined by a molar partition coefficient defined as  
ሿ ൈ ሾܪଶሾܦௐ
0ሿ
ሿ 
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where [DL], [L], [H2O], and [DW] stand for the concentrations of drug in the lipid phase, lipid, 
water, and drug in water phase, respectively. The molar fraction of bound drug XD is defined as 
௅ሾܦൌ஽ܺ ሾܮ
ሿ
ሿ 
we can thus derive the equation linking the molar fraction of the bound drug with the molar 

partition coefficient:
 
ሾൌ஽ܺ ଶܪ
௉ܭ
ሿܱ
ሿ்ܦሾ
൅ ܭ௣ ൅ ሿܮሾ
where DT stands for total the total drug concentration ([DT]=[DW]+[DL]). Even this approach has 
some problems associated with it. Kp well describes the association of drugs to lipids at low mole
fractions, however drugs, especially drugs carrying a charge, tend to affect their own binding,
usually decreasing the apparent Kp as a function of XD. This can usually be neglected if just
comparing the binding of a drug to different lipids. 
Moreover, discussion about drug lipid interactions often focuses on the drug concentrations
utilized in the experiments, whereas it would be more appropriate to discuss the amount of 
membrane associated drug or the molar fraction of the drug within a given membrane. This 
approach not only takes into account the drug concentration but also associates it with the lipid
concentration of the system under study. It is important to emphasize that drugs are generally not
equally distributed in an organism. Even the intracellular distribution is unequal, partly due to the 
chemical properties of drugs and partly due to the metabolism and detoxification routes of cells
leading to up to 1000-fold concentration differences in drug concentration in cellular
compartments even within a single cell (De Duve et al. 1974; Trapp and Horobin 2005). This can 
cause accumulation of drugs in certain cellular compartments, such as lysosymes, where the 
effective drug concentrations can become high enough to interfere with lipid-protein interactions 
in cells. Taking this into consideration corroborates the importance of understanding how 
membrane associated drugs affect the function of these organelles.
Several techniques have been used to define the membrane partitioning of drugs. Equilibrium
dialysis assays with radiolabeled drugs, in which the drug is left to partition into a liposomal 
solution of preferably LUVs with subsequent determination of the respective drug concentrations 
in the lipid containing and lipid free solution compartments have been used. This method, 
however, is tedious with equilibration times up to weeks, and requires the use of radioactive
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compounds (Kwon et al. 2007). Second derivative absorption spectroscopy can be used if the signal 
is affected by lipid binding (Kitamura et al. 1995; Santos et al. 2003; Takegami et al. 2005). Recently 
a more common approach has been use of fluorescence spectroscopy utilizing the changes in the
fluorescence of the compound studied if applicable or the use of fluorescently labeled lipids
(Luxnat and Galla 1986; I). The advantage of spectroscopic techniques is the lower consumption of 
drugs together with the relative simplicity of the measurements, allowing for screening of large
groups of compounds. Surface plasmon resonance (SPR) can give good results and is not biased by
the use of labeled compounds. There are, however, problems related to membrane preparation for
SPR. Namely, it is argued whether immobilized vesicles fuse into a bilayer, or remain intact. This 
can further cause problems in the interpretation of the data, if for example the added compound
causes the vesicles to fuse (Abdiche and Myszka 2004). Recently even techniques based on the use
of supported phospholipid bilayers (Tamm and McConnell 1985) have been developed for high-
throughput screening of compound libraries (Loidl-Stahlhofen et al. 2001a; Loidl-Stahlhofen et al.
2001b). 
The activity and membrane association of peripheral and integral membrane proteins is affected
by a number of parameters (Subramanian et al. 1998). Direct effects of a ligand on protein activity 
caused by ligand binding to a specific binding site are the easiest to understand. However, protein
activity is also affected by e.g surface potential, lateral pressure, membrane fluidity, curvature, 
dipole potential, and bilayer elasticity, many of which are properties also affected by the interaction 
of drug compounds with phospholipid membranes. Given that equations commonly employed to 
fit binding such as the Hill equation (Cantor 1999b) describing allosteric effects on proteins can 
give good quality fits even in this case. However, it is almost impossible to distinguish between the 
direct drug effects on proteins and the indirect effects caused by changes in the membrane
properties in the vicinity of the receptor. 
The electrostatics of phospholipid membranes allow for another possible factor to affect the
binding of drugs. First of all anionic lipids attract cationic drugs simply due to electrostatics.
However, even more avid interactions can form as a result of correct matching of the shape and 
charge distribution of a drug. If the drug forms a suitable dipole compatible with the dipole of the
phospholipid head group, it will favor drug association. This has been recently suggested to  
underlie the enhanced partitioning of many halogenated compounds to membranes even though 
logP is not necessarily increasing due to this chemical modification (Alakoskela et al. 2009). 
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2.3.2 Lipids as drug targets 
Few examples exist, where it has been shown that a drug or compound actually exerts its action via
direct interactions with phospholipid bilayers. Polyene antifungal agents such as Amphotericin B
were originally extracted from Streptomyces nodosus. They are widely used in clinical work to treat
invasive fungal infections mainly in immunocomprimised patients (Ablordeppey et al. 1999). 
Amphotericin B acts via interacting with ergosterol, the main steroid component of fungal 
membranes, forming a pore allowing the exchange of ions across the membrane. Even though this
hypothesis has been proposed more than 30 years ago (Andreoli 1974; de Kruijff and Demel 1974),
direct evidence of the interaction between amphotericin B and ergosterol was only recently first
demonstrated by NMR techniques (Matsumori et al. 2009).  
Antimicrobial peptides have lately been under intensive study, and several modes of interaction
with various types of membranes have been shown. Lately a lot of effort and funds have been put
in understanding diseases involving amyloid formation. Amyloids are insoluble alternatively
folded (Dobson 2003) protein aggregates accumulating in e.g. Alzheimer’s disease. It has been
established that anionic lipids promote the formation of such aggregates in vitro. Amyloid
formation involves several steps from reversible oligomerisation of proteins into functional units
to formation of the inactive, insoluble mature amyloid seen in various pathological conditions
(Gorbenko and Kinnunen 2006). It has been suggested that oligomerisation of proteins acts as a 
way to conveniently regulate their activity (Code et al. 2008). Peptides such as LL37 (Sood et al.
2008), temporins (Code et al. 2009; Mahalka and Kinnunen 2009), endostatin (Alakoskela et al.
2006; Zhao et al. 2005) and indolicidin (Zhao et al. 2001), have been shown to associate with
phospholipid vesicles. 
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Fig. 6 The chemical structures of chlorpromazine (left) and siramesine.
2.3.3 Chlorpromazine (CPZ) 
In this study we used chlorpromazine (CPZ, Fig. 6), a widely used classical antipsychotic drug as a
model compound. As an amphiphile with an appropriate surface activity profile it readily crosses
the blood-brain barrier (Suomalainen et al. 2004), partitions into cellular membranes and elicits its 
effects on the central nervous system by influencing various transmitter systems in the human
brain (Mycek 1997). Conventionally specific receptor-mediated interactions have been thought to 
account for most of the observed actions of CPZ in humans and that binding to dopaminergic
receptors is mostly responsible for the beneficial effects of CPZ seen in patients suffering from
schizophrenia. It remains uncertain, however, if binding to different receptors and the effects 
mediated through them are alone enough to describe all the diverse actions of this compound. CPZ 
has been shown to avidly bind phospholipid membranes (Conrad and Singer 1981; Luxnat et al. 
1984) with direct effects on their structure, organization, and dynamics (Jutila et al. 2001). CPZ has 
a high affinity to acidic phospholipids, such as phosphatidylserines (PS) and phosphatidylinositols 
(PI), which are commonly found in the inner leaflet of the plasma membrane (Bretscher 1972;
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Dolis et al. 1997). Interestingly, in mouse synaptosomal membranes up to 20% of the total PS is 
located in the outer leaflet (Devaux 1991). Considering the affinity of CPZ to negatively charged
lipids the availability of PS on the cellular surface could thus provide an additional receptor for this
drug, for instance when considering potential interference with lipid-protein interactions of 
membrane associating proteins by CPZ (Jutila et al. 1998). Nuclear magnetic resonance and
electron spin resonance studies on model membranes have shown that CPZ binds to the head
group region as well as intercalates into the membrane between the acyl chains (Nerdal et al. 2000;
Underhaug Gjerde et al. 2004). This is supported also by monolayer studies showing that CPZ 
increases the surface area/molecule for certain phospholipid species (Agasosler et al. 2001; Varnier 
Agasoster and Holmsen 2001).  
2.3.4 Siramesine 
Siramesine ((1'-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]-1-butyl]spiro[isobenzofuran-1(3H),4'­
piperidine], SRM,Fig. 6) was originally synthesized by H. Lundbeck A/S for the treatment of 
anxiety. Phase II trials showed this compound to be non-toxic and well tolerated in humans.
However, the clinical efficacy was not satisfactory and its development was discontinued in 2002 
(Heading 2001). The primary target of SRM has been suggested to be the σ-2 receptor (Soby et al. 
2002), an orphan receptor with no endogenous ligand known. These receptors have unique drug
interaction profiles binding for instance haloperidol and sertraline and their activity has been 
associated with various psychiatric disorders (Guitart et al. 2004). The physiological functions of σ­
receptors remain unknown. The σ-1 receptor has been cloned, whereas the σ-2 receptor still needs 
to be isolated (Colabufo et al. 2006). The latter have been found to be associated with the so-called
lipid rafts (Gebreselassie and Bowen 2004). Interestingly, σ-receptors are abundant in many
malignant cells and there is evidence suggesting their crucial role in cell proliferation (Vilner et al.
1995). Along these lines, SRM has been recently demonstrated to suppress the growth of several 
cell lines in vitro and it has also been shown to inhibit the growth of solid tumors in mice 
(Ostenfeld et al. 2005). 
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2.3.5 Anesthetics and lipids 

Anesthesia is needed on a daily basis in clinical medicine, allowing surgical procedures. It is
commonly divided into three parts: hypnosis, relaxation and analgesia. These three can be induced
by one compound or a combination of different drugs can be used. Surprisingly, despite the fact
that the first public demonstration of ether anesthesia by Dr. William T. Morton dates back as
early as 1846, the molecular level mechanism underlying general anesthesia remains elusive.
According to the Mayer-Overton rule, anesthetic potency of a given substance correlates well with
the mineral oil/water partitioning of the substance irrespective of molecular size or chemical 
structure. This rule applies well to volatile anesthetics over a wide range of molecules, the simplest
being the noble gas xenon up to more complex compounds, and stands over several orders of
magnitude of molecular size. This lead to the lipid mediated anesthesia hypothesis which has been 
widely studied over the past decades (Seeman 1972). Factors such as solubilization of the nerve cell 
membrane and changes in the phase transition temperature together with curvature and dipole 
potential changes have been proposed to underlie these effects (Cafiso 1998; Cantor 2001;
Heimburg and Jackson 2007). In recent years, however, increasing evidence suggesting the
importance of especially the complex and extensive GABA receptor family with a multitude of 
various combinations of receptor subunits, with different drug binding properties etc. has been
gathered. Maybe the most important finding opposing the idea of anesthesia induced by direct, 
nonspecific actions of compounds on the lipid bilayers is the lack of specific membrane effects of
the stereo-isomers of steroid anesthetics (Antkowiak 2001). A range of compounds exist of which
one stereoisomer is anesthetically active, where as the other is not (Covey 2009). Studies on C.
elegans have been conducted, as well as fluorescence studies (Alakoskela et al. 2007). The mineral 
oil/water partitioning is not affected by the stereochemistry, nor has it been possible to distinguish 
any other property in lipid bilayers that would explain the difference in potency of these
substances. One plausible explanation could be that the binding site for the anesthetic molecule
resides in the transmembrane part of the receptor protein. This would require the compound to
first partition into the membrane prior to being able to interact with its target (Grasshoff et al. 
2006). It can of course be argued, that the stereo specificity lies somewhere else in the organism 
than in the membrane, e.g. differences in detoxification leading to different effective 
concentrations of a given substance.
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2.3.6 Phospholipidosis 
Phospholipidosis is a pathological condition characterized by phospholipid accumulation in
lysosomes (Reasor et al. 2006). Under electron microscopy the affected lysosomes have a typical 
pattern of membrane stacking (Kodavanti and Mehendale 1990). The earliest descriptions of the
condition date back to the 1970s (Lullmann-Rauch 1979). Lysosomes have an important role in 
lipid degradation, since as a side product of organelle autophagy and endocytosis lipids, including
sphingolipids, cholesterolesters and glycerophospholipids, end up in lysosomes for degradation by
phospholipases (Johnson et al. 1996). 
Interestingly, phospholipidosis is induced by a variety of different drug compounds, mainly
cationic amphiphilic drugs. It is hypothesized that phospholipidosis is caused by drug induced 
inhibition of the phospholipid degradation in lysosomes. Three prerequisites have been identified
for a drug to be able to induce phospholipidosis, 1 it must enter the cell, 2 it must be enriched in 
lysosomes, and 3 it must inhibit the activity of lysosomal phospholipases A and C (Hostetler 1984).
Many of the compounds inducing phospholipidosis differ from each other significantly both
structurally and by their receptor binding profiles, thus suggesting a more general mechanism of
action behind the observed phospholipid accumulation. Since lysosomes are rich in anionic 
phospholipid species it has been suggested, that the underlying cause of phospholipidosis is the
interference of the accumulated drugs with the normally membrane associated proteins requiring
anionic lipids for their activity (Alakoskela et al. 2009). The significance of phospholipidosis 
remains somewhat unclear, since this disorder of a cellular organelle seems quite isolated. There is 
a correlation that drugs efficiently inducing phospholipidosis are often toxic, however even 
nontoxic drugs may cause this disorder. Pharmaceutical companies screen for phospholipidosis
using cell based assays, this however, is tedious and expensive (Kasahara et al. 2006). This has lead
to the development of another approach in screening for phospholipidosis, namely screening for
the interaction of drugs with anionic phoshpholipids, by observing the change in the apparent 
CMC of a short chained phosphatidylserine due to interaction of drugs (Vitovic et al. 2008). 
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2.3.7 Proteins requiring a special lipid environment 
Together with the recent advances in protein and lipid research technologies the detailed crystal 
structure of many transmembrane proteins has been solved. This has revealed some intriguing
details about proteins having specific binding pockets for lipids, not only on the surface of the 
membrane spanning parts but also inside the protein molecules. It has been shown that cholesterol 
is needed to stabilize the structure of the nicotinic acetylcholine receptor (Brannigan et al. 2008).
Further, the lipid composition of the immediate surroundings of this receptor is important in 
regulating the activity of the nicotinic acetylcholine receptor (Barrantes 2004; Bhushan and
McNamee 1993; Dickey and Faller 2008). The presence of PA in the membrane was required to
activate the protein, in the absence the protein is stabilized in a resting conformation. Such binding 
sites within the membrane open interesting prospects for further projects. Other membrane
properties shown to affect protein activity involve surface dipole potential (Poolman et al. 2004),
membrane thickness (Xu et al. 2008), lateral pressure (Kung 2005), membrane curvature
(Lehtonen and Kinnunen 1995a; Nylund et al. 2007), and membrane elasticity (Sogaard et al.
2006). 
2.4 Lipids in drug delivery & transfection 
10 years ago a lot of time and money was spent in solving the genetic code. It was postulated that it 
would open the way to treatment of many so far untreatable or lethal diseases such as many forms
of cancer, diabetes etc. In the post genomic era, that is after the human genome was published 
(International Human Genome Sequencing Consortium 2004) many of these fundamental goals 
have not been reached. 
One key issue in replacing a malfunctioning or faulty gene is to introduce the working copy to the
organism and furthermore to the organ in question. A traditional way to accomplish this so called
transfection is to use nature’s own transfecting agents, viruses, to carry the genetic material to its 
target. This, however, poses some drawbacks. Since viruses are pathogenic it is imperative to
abolish the infectious material from the virus prior to introducing the particle to the target. Even
when this is successfully accomplished the immune system of complex organisms is prone to
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attack this foreign material (Thomas et al. 2003). Consequently, an intensive search for a safer
transfection vector is ongoing. One successful approach has been the use of cationic liposomes,
which bind and form complexes with DNA to transport the genetic material to cells (Felgner et al.
1987; Ryhänen et al. 2003). This is a safer approach, since cationic lipids are not infectious. It is 
also possible to find non-toxic compounds, that generally do not cause strong immune responses
in the target organism. So far transfection efficacy has been the major advantage of viral
transfection. Therefore the properties responsible for the transfection efficacy of lipids and lipid-
DNA complexes have been studied over the past years in order to find more effective liposomal 
compounds. Other means of increasing transfection efficacy involve increasing the cirulation half­
time of liposomal particles by coating them with for instance polyethyleneglycol (PEG). Another
line of research deals with targeting such compounds to various tissues with the help of peptides or
other molecules that find specific targets at the desired place of action. It has also been proposed
that incorporating reactive groups, such as disulfide bridges in the spacer of a gemini surfactant 
lipid could facilitate the release of DNA from such vesicles (Säily et al. 2006). 
In addition to introducing genetic material to cells liposomes can and have been employed as 
transport vehicles for more conventional drugs. There are several advantages in packing drugs into
liposomal carriers. The circulation half-time of a drug is increased, thus providing a more stable
drug concentration in circulation. Liposomes can be used to mask the drug molecule, which 
otherwise would cause an immunological response (Blume and Cevc 1990). 
Future prospects involve constructing functional liposomes or liposomes that can be packed with a 
drug, targeted to a specific location and triggered to release their content as a response to some
stimulus such as pH, temperature, or a chemical gradient. Methods such as focused ultrasound are 
being studied in order to create such functional nanoparticles. One practical approach involves
triggering a phase transition in the carrier vehicle, as during the main transition a maximum in 
permeability of the liposome occurs, allowing it to deliver its cargo. Therefore it is important to 
understand the molecular events underlying lipid phase transitions and the various factors
affecting those. 
Specific issues to be considered upon designing new biologically active functional nanoparticles
involve factors such as keeping the particles in circulation, finding the desired target, penetrating
the target and subsequently delivering the cargo into the nucleus to incorporate the functioning
gene into the genome.  
33 

  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
3 Aims of the study 
This thesis focuses on the relationship of the organization, function and phase behavior of model
membranes, together with drug-effects on membranes.
The first aim of this study was to develop a fluorescence quenching based assay for fast and
convenient quantification of the membrane association of various membrane active compounds. 
In the second part the first described method was employed to assess the membrane binding
properties of siramesine, a drug recently found to cause apoptosis in cancer cells and hypothesized
to interact in a non-specific way with cellular membranes. 
The third part focuses on the different behavior of the commonly used membrane models large
unilamellar vesicles (LUVs) and multilamellar vesicles (MLVs) to I) get insight into the effect of 
lamellarity on membrane properties and II) to more thoroughly characterize the effects of the
commonly used fluorescent probe 1-Palmitoyl-2[10-(pyren-1-yl)]decanoyl-sn-glycero-3­
phosphocholine (PPDPC) on the biophysical properties of the lipid membrane, further aiding the 
interpretation of studies employing this fluorescent lipid analog. 
In the fourth and final part the organization of cationic liposomes in the presence of salts is
studied. The reasoning behind involves the use of cationic liposomes as gene transfection vectors
requiring understanding of the assembly and structure of such nanoparticles.
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4 Materials and methods 
4.1 Chemicals 
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, (POPC), and 1-palmitoyl-2-oleoyl-sn-glycero­
3-(phospho-l-serine), (POPS), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol (POPG),
1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn­
glycero-3-phosphoinositol (POPI), 1,2-dipalmitoyl-sn-glycero-3-phospho[N-(4-nitrobenz-2-oxa­
1,3-diazolyl)]-ethanolamine (DPPN), 1,2-dioleyl-sn-glycero-3-phosphoethanol (DOPet), 1,2­
dioleyl-sn-glycero-3-phosphomethanol (DOPmet), 1-stearoyl-2-hydroxy-sn-glycero-3-phosphate
(Lyso-PA), and 1-stearoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (Lyso-PG) were 
from Avanti Polar Lipids (Alabaster, AL). 1-Palmitoyl-2[10-(pyren-1-yl)]decanoyl-sn-glycero-3­
phosphocholine (PPDPC) was from K&V Bioware (Espoo, Finland). (1'-[4-[1-(4-fluorophenyl)­
1H-indol-3-yl]-1-butyl]spiro[isobenzofuran-1(3H),4'-piperidine] (SRM) was kindly provided by 
H. Lundbeck A/S (Copenhagen, Denmark). Deionized Milli-Q (Millipore, Bedford, MA) filtered
water was used in all experiments. 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes),
NaCl, ethylenediaminetetraacetic acid (EDTA), Chlorpromazine (CPZ), and egg yolk­
phosphatidic acid (egg-PA) were from Sigma-Aldrich (St. Louis, MO, USA) . All chemicals were of 
analytical purity. The lipids were analyzed by thin layer chromatography on silicic acid coated
plates, developed with chloroform/methanol/water/ammonia (65/20/2/2, by volume) as the 
solvent. No organic impurities were detected upon examination upon UV-illumination or after
iodine staining. 
Lipid and drug concentrations were determined gravimetrically using a high precision
microbalance (Cahn Instruments Inc., Cerritos, CA). The concentrations of PPDPC, DPPN and
CPZ were determined from their absorption spectra (Cary-100 Bio, Varian Inc, Victoria,
Australia) recorded using quartz cuvettes with one cm pathlength and employing 42,000 M-1cm-1 at 
342 nm, 21,000 M-1cm-1 at 463 nm, and 24,000 M-1cm-1 at 254 nm, as their molar extinction 
coefficients, respectively. Stock solutions of SRM and CPZ were made in chloroform. Proper
aliquots were dried under a gentle flow of N2 and the dry residue dissolved in dimethylsulfoxide
(DMSO, Merck), ethanol, or buffer as indicated. The molar absorptivity of SRM was 20,000 M-1cm­
1 at 258 nm determined from its absorption spectra recorded for a 10 μM solution in ethanol.
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4 Materials and methods 

4.2 Preparation of liposomes (I-IV) 
Upon hydration a dried phospholipid film forms multilamellar vesicles, with a diameter of
typically 200-1500 nm and with multiple overlapping lipid bilayers forming a shape resembling the
structure of an onion. Depending on the desired application or experimental conditions MLVs can
further be processed e.g. extruded through 100 nm polycarbonate filters to yield large unilamellar 
vesicles (LUVs), commonly employed in fluorescence spectroscopic experiments.  
More specifically, thelipids were dissolved in chloroform and subsequently mixed in this solvent so 
as to obtain the desired compositions. The solvent was removed using a gentle stream of nitrogen 
whereafter the dry lipid residues were maintained under reduced pressure for at least 2 h in order
to remove trace amounts of chloroform. The lipids were hydrated with 20 mM Hepes, 0.1 mM
EDTA, pH 7.0. During hydration the dispersing was aided by a shaking water bath at room
temperature so as to yield multilamellar vesicles. Where desired, large unilamellar vesicles (LUV) 
were prepared by extrusion using a LiposoFast (Avestin, Ottawa, Canada) small-volume
homogenizer. The lipid dispersions were passed 19 times through polycarbonate filters with an
average pore diameter of 100 nm (Millipore, Bedford, MA), in order to yield LUVs with an average
diameter of 80 ± 25 nm (MacDonald et al. 1991). 
4.3 Fluorescence spectroscopy (I-III) 
For fluorescence spectroscopy we incorporated fluorescent lipid analogs in the liposomes. PPDPC
(I-III) was chosen because its pyrene moiety was covalently attached to a decanoyl chain at the sn-2
position. The photophysics of pyrene, namely its propensity to form excited dimers, excimers,
upon collision of an excited pyrene with a ground state pyrene make it a suitable probe to reflect
the lateral movement of lipids in a bilayer (Galla and Sackmann 1974; Lehtonen and Kinnunen 
1994; Muller et al. 1986). The pyrene moiety resides in the hydrocarbon region of the membrane.
Accordingly, for collisional quenching to occur, the quencher needs to penetrate the membrane
core. DPPN (II) was chosen as a second probe, since it carries a fluorescent NBD-group covalently
attached to the head-group, thus being susceptible for quenching if the quencher is enriched on the
membrane surface.(Alakoskela and Kinnunen 2001) Steady-state fluorescence spectra were
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measured in four window quartz cuvettes with one cm pathlength, using a fluorescence
spectrophotometer (LS-50B, Perkin-Elmer, MA, USA (I) or Varian Cary Eclipse (II, III) Varian
Inc.) equipped with thermostated temperature controlled cuvette holder. The excitation and
emission wavelengths were selected according to the probe in question as indicated. Emission and
excitation bandpasses were set at 5 or 10 nm depending on the probe. If not otherwise stated
measurements were conducted at 25° C. 
4.4 CMC determination (II) 
The critical micelle concentration (CMC) for SRM was determined at ambient temperature
(approx. 22 °C) with an 8-channel surface tension platereader (Delta-8, Kibron Inc., Espoo,
Finland). For these measurements serial dilutions prepared in 96-well plates (DynePlates, Kibron) 
in the indicated concentration range were employed. The data were analyzed utilizing the Gibbs 
adsorption isotherm embedded in the dedicated software from the instrument manufacturer
(Delta-8 Manager).  
4.5 Binding of SRM to lipid monolayers (II) 
Penetration of SRM into monomolecular lipid films was measured using a Langmuir-tensiometer 
(DeltaPi, Kibron Inc., Espoo, Finland) with magnetically stirred circular wells with a subphase
volume of 1.2 ml (Multiwell plate, Kibron Inc.). Surface pressure π was monitored with a metal 
alloy probe hanging from a high precision microbalance (KBN129, Kibron Inc.). The indicated
lipids were mixed in chloroform (c=1 mM) and spread on the air–water interface using a 
microsyringe. The monolayers were allowed to equilibrate for 5 to 15 min to reach the indicated 
initial surface pressure values (π0). 4.8 μl of 0.4 mM SRM (dissolved in DMSO) was then injected
the subphase (20 mM Hepes, 0.1 mM EDTA, pH 7.0) to yield a final drug concentration of 1.6 μM.
This amount of DMSO as such had no effect on the surface pressure. The difference between π0 
and the final surface pressure after the addition of drug was taken as the increase in surface
pressure (Δπ). The data are represented as Δπ vs. π0, thus revealing the effect of increased lateral 
packing on the penetration of the drug into the monolayer (Brockman 1999).
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4 Materials and methods 

4.6 Differential scanning calorimetry (DSC) (II-III) 
The indicated amounts of the drug and lipids were mixed in chloroform. These mixtures were
dried under a stream of nitrogen and subsequently kept under reduced pressure for at least 2 h to 
remove traces of the solvent. The samples were hydrated in 20 mM Hepes, 0.1 mM EDTA, pH 7 at
60 °C for 30 min in a shaking water bath as to yield multilamellar liposomes utilized in the DSC
measurements. The samples, final lipid concentration 0.4 mM, were equilibrated on an ice
waterbath for at least 10 h to ensure equal thermal histories. The endotherms were recorded using
a microcalorimeter (VP-DSC, Microcal Inc., Northampton, MA) at a heating rate of 30 deg/h. All
scans were repeated to assure their reproducibility. Deviation from the baseline was taken as the 
beginning of the transition and return to the baseline as its end. The endotherms were analyzed
using the routines of the software provided by the instrument manufacturer. 
4.7 Optical microscopy of a liposome solution (IV) 
An Olympus IX-70 inverted microscope with differential interference contrast optics was used to 
observe the microscopic changes in the surfactant suspension upon heating from 24 to 50 °C by a 
Peltier element controlled thermal microscopy stage (TS-4, Physitemp, Clifton, NJ, USA) The 
images were captured using an attached Canon Eos 10D SLR camera. The surfactant suspension
(1.5 ml) with the indicated [NaCl] was applied into a chamber with quartz glass bottom.  
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5 Results 
5.1 Interactions of cationic amphiphilic drugs with liposomes 
5.1.1 Reversible binding of CPZ to liposomes (I) 
Our preliminary experiments demonstrated that CPZ quenches pyrene fluorescence emission by 
acting as a collisional quencher, most likely involving the aromatic ring structures of CPZ (See
above, Fig. 6). Accordingly, binding of CPZ to liposomes can be monitored by observing changes
in the fluorescence emission from the pyrene-labeled phospholipid analog PPDPC. 
For PPDPC liposomes with XPC=1.0 (20 μM total lipid), 40 μM CPZ reduced the fluorescence 
intensity to 15% of the initial value (Fig. 7), with no further decrease at higher [CPZ]. In keeping 
with the high affinity of CPZ to the anionic phosphatidylserine (POPS) (Chen et al. 2003),
significantly enhanced quenching was observed in the presence of this lipid in the bilayers (Fig. 7).
Accordingly, only 4 μM CPZ was needed for similar quenching with liposomes containing
XPS=0.50, compared to neat POPC liposomes requiring ten times higher [CPZ]. Saturation was 
observed already at [CPZ]=6μM. Upon further increase of XPS up to 0.99 no further enhancement
was observed. The reversibility of this 
interaction was studied by adding
phospholipid vesicles without the 
fluorescent probe to allow for a 
redistribution of the drug between the
original labeled and the unlabeled 
vesicles. Assuming that CPZ is evenly 
distributed between the liposomes, we 
can depict the values for RFI against the 
assumed mole fraction of CPZ in the 
labeled liposomes. The exact matching of
the data (I:Fig. 3) reveals that the drug is 
evenly distributed between the labeled 
and unlabeled vesicles, reflecting their
respective concentrations. 
Fig. 7 Quenching of pyrene monomer fluorescence by CPZ. 
PC LUVs at 25°C in 20 mM Hepes, 0.1 mM EDTA, pH 7.0
with XPPDPC=0.01. Vesicles with XPS=0 (), 0.05(), 0.1(), 
0.2(), 0.5 ()and 0.99()Figure I:2 reproduced with 
permission of Springer.
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5 Results
 
5.1.2 Calculating the molar partition coefficient for CPZ and SRM (I, II) 
In order to determine the molar partition coefficient for the studied drug-liposome interactions
quenching data from two series of measurements were collected. More specifically, in the first
series the phospholipid concentration was maintained constant and the drug concentration was 
progressively increased. In the second series the concentration of the drug was constant and the
phospholipid concentration was increased by adding increasing amounts of unlabeled liposomes.
The fluorophore concentration was held constant throughout the titrations in order to have an 
indicator of drug distribution as described below in detail. These data are compiled in Table I.
The molar partition coefficient Kp is defined by
[ ]L [H OD 2 ]Kp = ⋅[ ] [  ]DL W , 
where [DL], [L], [H2O], and [DW] stand for the concentrations of drug in the lipid phase, lipid, 
water, and drug in water phase, respectively. Of course, this partition coefficient can only be
applied for relatively low drug concentrations when the drug does not significantly change the
properties of the bulk phase (usually the lipid phase). Thus, for relatively low membrane drug
concentration we have 
[ ]DLXD ≈ [ ]L , and further
[ ]H 2OKp = XD ⋅ [ ]DW , 
in which XD is the mole fraction of drug in the membrane. Using the relationships between the
total drug concentration and the drug concentrations in the different phases we get 
p[ ]TK DXD = [ ]  [ ] , H 2O +Kp L 
where DT stands for total drug concentration. Evaluation of the partition coefficient was based on 
the assumption that in both of the above two experimental conditions at identical mole fractions of
bound drug in the bilayer (XD) the quenching efficiency should always be identical. Accordingly,
each RFI value corresponds to a unique XD, although the absolute numerical value of XD is not
known. The cubic interpolation function of Matlab (The MathWorks, Natick, MA) was used to 
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retrieve the drug concentrations in the second series that would produce identical RFI values to
those of the first series. This yielded a series of paired values (Table II), in which each unknown XD 
corresponds to two different combinations of the concentrations of drug and phospholipid.  
We then assumed that the data could be described in terms of a single, concentration independent
lipid/water partition coefficient. An initial guess of the partition coefficient was made and
subsequently the mole fractions for constant drug concentration (XC,i) and constant phospholipid
concentration (XL,i) corresponding to each RFIi were calculated. Ideally, with the correct Kp, for 
each value of i the equality XC,i= XL,i should apply. Subsequently, by varying Kp we minimized the
following sum:  
2
 




X
5 C ,i
 
i=1 
 
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 L,iX

 
L ,i 
in which (1- XC,i/XL,i)2 requires that the values in each pair should be equal. Accordingly, this gives
identical weight to relative variations for each XD, whereas larger weight is given to higher values of 
XD by weighing this term with XL,i. Alternative weighing, like using (XC,i-XL,i)2 would give identical
weight to differences from pairs like XC,i=0.02, XL,i=0.04 and XC,i=0.28, XL,i=0.30. On the other
hand, using (1- XC,i/XL,i)2 without weighing would give identical weighs to differences from pairs
like XC,i=0.02, XL,i=0.03 and XC,i=0.20, XL,i=0.30. The weighing scheme used is thus an intermediate
between the two extremes.
For vesicles with XPS=1.0 the above sum could be minimized by setting the value of the molar
partition coefficient to (2.2±0.2) ×107, which corresponds to (5.1±0.6) ×105 on volume/volume 
basis. The molar partition coefficient of CPZ in DPPC bilayers has been previously determined as 
(8.0±0.7)×104 (Luxnat and Galla 1986). The presence of negatively charged lipids enhances the 
binding of CPZ to membranes. The partition coefficient of CPZ to acidic phospholipids containing 
membranes has been calculated in a second-derivative spectrophotometry study and reported as 
(5.33±0.43)×105 for vesicles containing egg yolk phoshpatidylcholine (PC) and bovine brain PS,
80% and 20% respectively in the presence of 50 mM NaCl (Takegami et al. 2005). Accordingly, 
comparing these values to those in literature for the partitioning of CPZ reveals more than a 
tenfold increment in the partitioning of CPZ to pure POPS vesicles as compared to DPPC vesicles. 
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5.1.3 Interactions of siramesine with phospholipids (II) 
As expected from its chemical structure (See above, Fig. 6) SRM is fluorescent. In ethanol it has  
absorption bands at 258 nm and 297 nm, and upon excitation at 258 nm a broad emission band
peaking at 356 nm is seen (II: Fig 2). The emission intensity was significantly reduced in water,
with a weak band centered at 425 nm. 
Further SRM is amphiphilic as demonstrated by its partitioning into the air/water interface (II: Fig. 
3). The recorded isotherm yields 37±6.7 Å2 as the interfacial area of SRM, with CMC observed at
32 ± 1.2 μM. As expected from the above, SRM partitions efficiently into phosphatidylcholine
liposomes, with a significant increase seen in its quantum yield together with a 4 nm blue shift in 
the peak wavelength (II: Fig. 2), suggesting SRM to become accommodated in a non-polar
environment, in the hydrocarbon region of the bilayer. 
As already demonstrated for several other membrane associating cationic drugs, anionic 
phospholipids promote the binding of SRM to bilayers. Accordingly, increasing the content of
phosphatidylserine XPS in liposomes caused a marked increase in the membrane binding of SRM as 
reflected by a pronounced increase in its fluorescence.  
In order to study the localization and to quantitate the association of SRM to liposomes we used
SRM as a quencher for trace amounts of different fluorescent lipid analogs. We first employed
PPDPC which was found to be collisionally quenched by SRM, reflecting efficient binding of SRM
to POPC vesicles and causing at a drug:phospholipid ratio of 1:2 a maximally 60 % decrement in
PPDPC emission. While the hydrophobicity of the pyrene moiety of PPDPC causes this 
fluorophore to reside in the hydrocarbon region of the membrane, its polarizability together with
cation-π interactions should prefer a more interfacial orientation(Hoff et al. 2005; Yau et al. 1998).
Interestingly, including PS (X=0.50) to the vesicles attenuated the quenching of PPDPC by SRM 
(Fig. 8) and increasing the content of PS further to X=0.99 augmented this effect, with only a 
minor decrement caused by SRM in PPDPC fluorescence. For vesicles with XPS=0.2 the quenching
was biphasic with the initial small decrement in fluorescence caused by 4 μM SRM (corresponding 
to an apparent drug:PS molar ratio of 1:1) being followed by a progressive and pronounced
quenching upon further increase in [drug]. This was further elucidated for vesicles with XPA=0.02,
0.05, 0.10, and 0.20. Similarly to XPS=0.2 quenching was biphasic (Fig. 8) with the discontinuity 
observed at SRM concentrations varying linearly with XPA and corresponding to an apparent 1:1
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drug:PA molar ratio. The above data suggest the formation of stoichiometric complexes by SRM
and PA on the membrane surface, preventing the penetration of SRM into the membrane
hydrocarbon region where the pyrene moiety of PPDPC is accommodated. 
This was confirmed using another probe DPPN bearing a fluorescent NBD label in the headgroup.
For this probe (X=0.01) and POPC vesicles, the decrement in fluorescence caused by 4 μM SRM 
was 50% (II: Fig. 6) and efficient quenching was observed also for PS containing LUVs (XPS=0.20) 
with little difference when compared to neat POPC LUVs. 
Fig. 8 Quenching by SRM of the pyrene-labeled phospholipid analog PPDPC (X=0.01) in POPC vesicles:
with XPOPS=0 ( ), 0.20 ( ), 0.50( ), and 0.99 ( ), panel A), and with XPA=0 ( ), 0.02 ( ), 0.05 ( ), 0.10 ( ), and 0.20
(■), panel B). Total phospholipid was 20 μM in 20 mM Hepes, 0.1 mM EDTA, pH 7.0, T=25 °C). Figure II:5 
reproduced with permission of ACS Publications. 
The partition coefficients for SRM between the aqueous solution and vesicles containing POPC, 
POPS, POPG, egg-PA, Brain-PI, POPE, DOPMe, DOPet, lyso-PA, and lyso-PG using the
headgroup labeled DPPN (X=0.01) as a fluorophore (II: Table 1). In keeping with the above
fluorescence studies SRM preferentially binds to acidic lipids, with the highest affinity KP=240±80 
x 106 measured for PA.  
To further assess the specificity of the binding and the preference of different cationic amphiphilic 
drugs for anionic phospholipids we determined the partitioning of chlorpromazine, doxorubicin,
clozapine, and haloperidol to vesicles containing PG, PA, or PS. The highest affinities of the above
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drugs were measured for PS, followed by PG, while the least affinity was observed for PA
containing vesicles (II:Table 2) 
The above quenching experiments suggest that SRM intercalates into the hydrocarbon region of
neat POPC bilayers, while in the presence of anionic lipids two modes of binding are evident: a 
high affinity binding site in the membrane surface with SRM bound to the acidic phospholipid 
headgroup, and a second site with the drug intercalating into the hydrocarbon region. To verify the 
above conclusions from the fluorescence quenching experiments study we measured the
penetration of SRM into lipid monolayers residing on the air/buffer interface (Fig. 9). In
accordance with the above fluorescence data a pronounced increase in surface pressure due to 
SRM added into the subphase was observed for pure PC films, while XPS=0.2 dramatically
decreased the penetration. This readily complies with an interfacial location of SRM in films
containing the acidic phospholipid. Intriguingly, the association of SRM to monolayers containing
PA is different from those with PS (Fig. 9), with high values for Δπ being measured. This is most 
likely caused by the more extensive
partitioning of SRM to PA together
with a pronounced relative increase in 
the effective headgroup size of this
lipid upon binding of SRM.  
Fig. 9 Intercalation of SRM into phospholipid monolayers. 
SRM (1.6 μM) added into the subphase and the increase in 
surface pressure Δπ vs. initial surface pressure π0 was 
recorded. The films were composed of POPC ○, POPC with
POPS (X=0.20, ●), and POPC with egg-PA (X=0.20, ■). The
lines represent linear fits to the data as a guide for the eye. 
Figure II:7 reproduced with permission of ACS. 
Publications.
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5.2 Thermal phase behavior of DPPC MLVs and LUVs (III) 
Temperature scans from 10 to 50°C were recorded for DPPC LUVs and MLVs involving
sequential Lc → L β’ → Pβ’ → Lα transitions, while monitoring fluorescence of PPDPC ( 
Fig. 10, III: Fig.1). The obtained values for Tm (III: Fig.2B) agree with the DSC data (Fig. 12, see 
below) up to XPPDPC=0.035, whereafter the fluorescence data shows slightly lower temperatures, 
most likely revealing a local enrichment of PPDPC during melting. The pretransition of MLVs (III: 
Fig.2A) shows a pronounced shift towards lower temperatures with increasing XPPDPC, reaching 
Tp=22 °C for membranes with XPPDPC=0.05, and indicating stabilization of the Pβ’ phase by PPDPC, 
increasing its span from 11.4 to 17 degrees (III: Fig.2C). This is most likely caused by partitioning
of this lipid analog into phase boundaries along the ripples together with poor partitioning into the
gel phase bilayer. For LUVs the pretransition is not clearly defined. A change in the slope observed
in the Ie/Im trace preceding Tm probably represents the beginning of the main phase transition ( 
Fig. 10B). 
For MLVs in the Pβ’ phase, a maximum in Ie at Tp is followed by a steep decrease and a further less
pronounced decrement upon approaching Tm. The change in excimer emission may be explained 
by the initial partitioning of the pyrene lipids along the more fluid line defects formed in the
membrane, thus limiting the collisions between molecules to take place in one dimension, followed
Fig. 10 Temperature scans employing PPDPC as a reporter monitoring thermal phase behavior of DPPC 
MLVs (panel A) and LUVs (panel B). Ie/Im, is plotted against temperature. Total phospholipid
concentration was 20 μM in 20 mM Hepes, 0.1 mM EDTA, pH 7.4, with XPPDPC=, 0.01(), 0.02 (), 0.03 
(),0.04(), and 0.05 (). Unpublished data. 
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by gradual partitioning of PPDPC into the melting surroundings of the line defects. The decrease
in Ie ends in a steep drop at the main phase transition, reflecting the melting of the chains allowing
unconstrained lateral diffusion of the labeled lipids within the bilayer surface, resulting in effective
dilution of the probe.  
For Im two processes are evident at Tm for both LUVs and MLVs. At low XPPDPC (up to XPPDPC=0.01) 
a decrease of Im is observed, together with a concomitant decrease in Ie. This is likely to relate to the
melting of the acyl chains, increasing the area/molecule in the bilayer, thus allowing water to
partition deeper into the membrane hydrocarbon region. This increase in polarity leads to a 
reduced quantum yield for pyrene fluorescence, evident upon approaching Tm until XPPDPC=0.01. 
However, further increasing XPPDPC enhances excimer formation below Tm, resulting in a net 
increase in Im at Tm due to the diminished excimer formation becoming dominant over the 
quenching. These two effects cancel each other out at XPPDPC=0.015, with no change in Im observed 
at Tm. 
For LUVs Ie/Im reaches its maximum slightly below Tm, reflecting the enrichment of PPDPC in a 
fluid phase concomitant with fast lateral diffusion, Ie thus reaching a maximum at a point at which
a sufficiently large proportion of the pyrene probe is enriched in a small region of fluid phase
membrane. Above Tm a percolation threshold is exceeded, allowing the initially clustered PPDPC
molecules to freely diffuse within the continuous fluid phase, reducing inter-molecular collisions.
Upon further increase in temperature the collision rate increases linearly, reflecting augmented 
thermal motion. 
The dependence of Ie/Im at a given temperature on XPPDPC was analyzed (III: Fig.3). For gel state
MLVs the Ie/Im ratio initially exceeds that for LUVs e.g. Ie/Im has approximately the same value
when XPPDPC=0.005 for MLVs and XPPDPC=0.025 for LUVs or when XPPDPC=0.010 for MLVs or
XPPDPC=0.045 for LUVs. A steep increase in Ie/Im until XPPDPC=0.02 is seen, however above this point 
the increment is significantly less pronounced. In the Lβ’ phase the excimer fluorescence from 
PPDPC outside the PPDPC-enriched clusters is probably negligible and the Ie/Im ratio is 
determined by two factors viz. the fraction of PPDPC in the clusters and the local PPDPC 
concentration within these domains. The decrease in the slope of Ie/Im vs. XPPDPC thus most likely
reflects reaching either the maximal fraction for the PPDPC enriched in domains or the maximal 
local concentration within these domains. For both LUVs and MLVs in the Pβ’ or Lα phases a linear
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5.2 Thermal phase behavior of DPPC MLVs and LUVs (III)
dependence of Ie/Im on XPPDPC was 
observed, in accordance with
previous studies and theoretical 
predictions concerning diffusion
0.35 
0.30 
reactions in 2-dimensions
0.25 (Martins et al. 1996). 
0.20 
In order to compare the acyl
0.15 chain order of DPPC MLVs and
LUVs upon heating, the0.10 
fluorescence anisotropy (r) of
T [oC] DPH-PC (XDPH-PC=0.005) was 
determined (Fig. 11). The values 
Fig. 11 Fluorescence anisotropy vs. temperature of DPPC MLVs 
for anisotropy did not reveal() and LUVs (), as observed by DPH-PC (X=0.005) in 20
mM Hepes, 0.1 mM EDTA, pH 7.4. [LIPID] was 50 μM. significant differences between 
Unpublished data. 
LUVs and MLVs in the Lc and Pβ’ 
phases. In keeping with the 
pyrene fluorescence, Tm reported by this probe is slightly lower for LUVs than for MLVs. In the Lα 
phase r was consistently approx 15% lower for LUVs than for MLVs, reflecting lower chain order
in the former bilayers. 
The heat capacity traces for pure DPPC MLVs show an asymmetric main transition peak at 41.2 °C 
together with a pretransition at 33.5 °C. The fluorescent lipid analog incorporated into the bilayer
represents a substitutional impurity in the membrane, and is thus expected to affect the melting
process, typically decreasing Tm. With increasing XPPDPC the heat capacity traces (Fig. 12) show a 
broadening of the endotherms toward lower temperatures, indicating decreased co-operativity of 
the transition (III: Fig. 6), together with a gradual decrease in the main transition temperature Tm. 
To further correlate the above fluorescence data with the thermotropic phase behavior of DPPC
MLVs and LUVs as a function of XPPDPC we measured their melting endotherms by DSC (Fig. 12). 
The lift-off temperature for the main transition peak (defined as T at which the endotherm initially 
deviates from the baseline) shifts to lower temperatures upon increasing XPPDPC. Variation of the
lift-off temperature was observed between independent samples, suggesting the extent of PPDPC 
segregation to vary, depending on the less tightly controlled cooling of the samples before the
measurement. To the right of the main transition endotherm of MLVs at XPPDPC>0.015 a small 
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shoulder is seen, which gradually develops into a separate minor peak for vesicles with XPPDPC>0.03
at T=41.2 °C, corresponding to Tm of (almost) pure DPPC, separating from the DPPC:PPDPC 
mixture. Estimated from the enthalpy of this peak the DPPC in the membrane represents approx.
1% of the total DPPC. The pretransition of DPPC can be observed at low XPPDPC, and upon
increasing XPPDPC it is dramatically shifted toward lower temperatures. This decrease in Tp is 
accompanied by broadening and lowering of the pretransition endotherm, disappearing at
XPPDPC=0.035 (Fig. 12). 
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Fig. 12 Excess heat capacity (cp) traces of 1 mM DPPC MLVs (panel A) and LUVs (panel B) in 20 mM Hepes, 0.1
mM EDTA, pH 7.4. The calibration bar corresponds to 2 kJ/deg mol-1. XPPDPC increases as moving up in the 
graph. For MLVs XPPDPC=0, 0.005, 0.01, 0.015, 0.0175, 0.02, 0.0225, 0.025, 0.03, 0.035, 0.04, and 0.05 and for LUVs 
XPPDPC=[0, 0.005, 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, and 0.05]. Unpublished data. 
For LUVs, pure DPPC produces a single asymmetric endotherm peaking at 41°C representing the 
main transition. As reported previously, the pretransition is poorly visible for pure DPPC LUVs by
DSC (Heimburg 2000). Incorporating the fluorescent lipid analog into LUVs lowered and
broadened the main endotherm, and shifted it toward lower temperatures. Similarly to MLVs, also 
for LUVs with XPPDPC>0.035 phase separation is evidenced by a small, high-temperature shoulder
in the main transition, centered approximately at 40.8°C. At high XPPDPC variation between 
independent samples increased, perhaps reflecting the effect of clustering of PPDPC upon sample
preparation and cooling.
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5.3 Counter-ion driven self-assembly of a cationic gemini surfactant (IV) 
Visual inspection of the gemini surfactant suspensions of M-1 at various [NaCl] upon hydration
revealed unexpected behavior of the lipid. More specifically, at [NaCl]< 1.5 M the suspensions
were optically clear, whereas at higher [NaCl] the suspension became bleary, with a bluish tint.
This was observed for [NaCl]=1.5 and 2 M at temperatures of approx. 60°C, and for [NaCl]=3M
even at ambient T (≈22°C). These phenomena were reversible, as cooling the suspensions at
[NaCl]=1.5 or 2M to 20°C resulted in a clear solution again. Changes in the optical density of the
solution are likely to result from a transition in particle size upon heating.  
This was further studied in a quartz bottomed chamber by optical microscopy. These experiments 
revealed the formation of giant vesicles as the chamber was heated on the stage. A tentative phase
diagram (Fig. 14) was constructed to elucidate the observed relationship between [NaCl] and T. At
[NaCl]=0.5M no visible structures were observed, and with [NaCl]=1 M only sporadic
microscopical vesicles appeared at T>43°C. Upon heating of a solution with [NaCl] > 1M a series
of transitions was observed as exemplified in the micrographs below with [NaCl]=2M (Fig. 15).
More specifically at 24°C no visible structures could be identified, upon heating to 29 °C tubular
structures started to arise at the air/water interface (Fig. 15a). Further heating to 33°C caused these
structures to fuse to round giant vesicles, also observed below the surface in the liquid (Fig. 15b).
These giant vesicles had an approximate diameter of 30-50μm, with significantly larger vesicles
occasionally seen. In this temperature range even cytomimetic vesicles with morphologies 
resembling those of living cells, with internal ‘organelles’ were observed (Fig. 15b, inset). Above
Fig. 14 A tentative phase diagram of the relation of 
[NaCl] and T on the microscopic morphology of the 
M1 water suspension. 
a) submicroscopic structures 
b) heterogenous giant vesicles (diameter 30­
50μm) 
c) homogenous vesicles of 10-15 μm diameter. 
For further details see text.
Figure IV:3A reproduced with permission of ACS
Publications.
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5.3 Counter-ion driven self-assembly of a cationic gemini surfactant (IV) 

T=36°C vesicle size started reducing towards T≈40 °C, 
where after a homogenous distribution of vesicles with a
diameter of 10-15 μM was seen (Fig. 15c). The observed 
transitions were named Tg and Ts referring to the 
formation of giant vesicles and smaller homogenous
aggregates, respectively.
Interestingly, the formation of more complex vesicular
structures such as tubular aggregates and cytomimetic 
vesicles, constituting of several embedded vesicles
required the presence of the air/water interface, as these 
structures were absent when the experiment was 
conducted in a sealed chamber. However the transitions 
from clear solution to GVs and further to smaller 
homogenous vesicles remained visible even under such 
conditions.  
Fig. 15 1 mM M-1 Surfactant solution 
in 2M NaCl as seen under the  
microscope at T=30 (a), 33 (b), 43(c) 
°C. The scale bar represents 100 μm. 
Figure IV:2 reproduced with 
permission of ACS Publications.
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6 Discussion
The unifying theme of the original publications (I-IV) is the relationship of the function and order
of biological model membranes. The motivation of the study was to further the understanding of
drug-lipid interactions as potential modes of action participating in the observed clinical effects of 
various drug compounds. The self assembly of lipid structures and the responses to changes in the
environment provide a possible tool for the controlled release of liposomal preparations of drug
compounds as well as gene delivery. 
6.1	 A fluorescence based assay for determining the molar partitioning 
coefficient 
Even though the use of fluorescent probes bears some problems as discussed in more detail below,
there are several advantages in the approach for determining the molar partition coefficient of 
drug compounds to phospholipid vesicles described in this study. First of all the fluorescent probe
is known to be located in the liposomes. If the fluorescence of the studied compound was to be 
used, the fluorescence might get contribution from water dissolved drug molecules or fluorescent 
drug-drug aggregates. Further, the affected fluorescent property is not of importance, as long as the 
bound substance causes a consistent change in the measured property. This approach can be used
to quenching, irrespective whether the mode of quenching is collitional or via resonance energy
transfer. Even ratiometric properties such as changes in Ie/Im could be used. 
The disadvantages of this type of approach include the fact that the compound under study must
affect the fluorescence of the probe in a dose dependent manner. Further the change in fluorescent
properties needs to be continuous i.e. there must not be any local minima, thus each drug 
concentration produces a unique value. The results can be biased if the partitioning is affected by
the drug or if the drug irreversibly binds to the liposomes. This will result in unequal partitioning
between the labeled and non-labeled liposomes leading to poor fits for the data. Such behavior can 
however be noticed during the fitting of data. This type of assay can be easily expanded for high 
throughput screening with the necessary robotics. 
52 

  
 
 
 
 
 
 
 
 
 
   
 
 
 
  
 
 
  
 
 
6.2 Phosphatidic acid as a drug target 

This method will obviously fail to give appropriate results, if the partitioning of a compound
cannot be described in terms of a simple partition coefficient. However, in this case the fitting of 
the data will give poor results and thus reveal such behavior.
6.2 Phosphatidic acid as a drug target 
Siramesine has been shown to inhibit the growth of solid tumors in mouse models as well as in cell
culture (Groth-Pedersen et al. 2007; Ostenfeld et al. 2005). Siramesine binds tightly to the orphan 
sigma-2 receptors, with a dissociation constant in the nanomolar range. The observed anti-tumor 
effects, however, still have a dose dependent response at 1-5 μM concentrations of the drug at
which the sigma-2 receptors should by far be saturated by the drug. This raises the question
whether there is another target behind the observed actions of the drug. In study II siramesine was
found to associate tightly with phospholipid membranes. It was found to form stoichiometric
complexes with anionic lipids of which especially the interaction with phosphatidic acid
containing membranes was avid. The partition coefficient for PA containing membranes was
found to be of an order of magnitude larger for this interaction as compared to the other studied
lipid compositions, roughly corresponding to a dissociation constant of 0.23 μM. The strong
interaction with PA may relate to the small head-group size of the lipid, allowing for tight 
association in the head-group region. PA has also been suggested to be deprotonated into a 
divalent anion, especially when hydrogen bonded (Kooijman et al. 2005; Kooijman et al. 2007). 
Considering the role of PA as a second messenger in cells the observed binding poses the question
of the potential biological relevance of this interaction. Several proliferative signaling pathways 
such as Raf, Ras, Sos, and mTor require PA for activity, more specifically crucial proteins need PA 
to bind to membranes in order to gain activity. The formation of a SRM:PA complex might
interfere with this binding, thus leading to detachment, and inactivity of these proteins (Fig. 16).
This provides an intriguing, simple molecular mechanism, possibly underlying the observed anti­
cancer activity of this drug. This is the first example in which a small molecular drug compound is
suggested to exert its effects via specific drug lipid complex formation, and opens a new paradigm 
in the search for anti-cancer drugs. Importantly, in the case of siramesine the interaction of the
drug with PA is not intentional from the point of view of the drug designer. In the future it might
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6 Discussion
 
Fig. 16 A schematic illustration depicting the role of PA in cellular signaling on the left and on the 
right the proposed mechanism of action of SRM blocking PA signaling and leading to the down 
regulation in signaling pathways requiring PA
be possible to directly target PA  with  even more  specific small molecule drugs with a further  
increased affinity for this target. 
6.3 Material properties associated with membrane stacking
In lipid research the model system is often chosen according to the desired application. LUVs are 
commonly employed for fluorescence studies, where as for DSC, X-Ray diffraction and NMR
techniques MLVs are commonly used. This relates at least partly to the idea that LUVs provide a 
more realistic model of a cellular environment, whereas MLVs produce better quality data on the
above named techniques. In biological systems or organisms unilamellar membrane assemblies are
common. Some examples, however, stand in which multilamellar membranes exist also in vivo
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6.4 Fluorescent probes as impurities in model membrane systems 

such as the myelin sheath of axonal nerve cells. The differences between MLVs and LUVs derive 
from the different vesicle size but also from the inter-bilayer interactions in a multilamellar system. 
The transitions for MLVs are more co-operative as seen by DSC. Furthermore DPPC MLVs have a 
clearly defined rippled phase, whereas in LUVs this cannot be clearly identified by DSC or PPDPC 
fluorescence. The fluorophore PPDPC was found to segregate into domains for both LUVs and
MLVs. For MLVs however, this segregation is much more pronounced, as evidenced by the high 
collision rate (Ie/Im values) of the pyrene molecules in gel phase liposomes. The fluorescence data 
also reveals a clear pretransition for MLVs, after which the collision rate of pyrene is decreasing
due to the liberty to redistribute along the formed membrane ripples upon heating. This behavior
is missing from LUVs as reflected by a continuous increase in Ie/Im up to Tm. Interlamellar
interactions are evident even in fluid phase vesicles, where MLVs have a lower collision rate of 
pyrene molecules as compared to LUVs. This was hypothesized to result from slower lateral 
diffusion within the membrane leaflets and could also be confirmed using DPH fluorescence as an
indicator.
6.4 Fluorescent probes as impurities in model membrane systems 
The fluorescent probes PPDPC and DPPN were used in this study to assess drug binding and the 
lateral organization of liposomes. Incorporating fluorescently labeled lipid analogs into an
otherwise pure membrane system allows for the use of very sensitive techniques to monitor small 
changes in the organization and dynamics of the system. The drawback is of course that 
incorporating fluorophores or other substances represent a substitutional impurity in the system 
under study and the effects seen might be due to the probe and not due to real effects on the lipid
dynamics. For example the fluorescent probe might affect drug binding, thus affecting the absolute
values of Kp. These types of effects can usually be neglected if just comparing different membrane
assemblies, keeping the probe concentration constant. When the results are compared to results
obtained by other methods, where the fluorescent probes are not needed they must be accounted
for by separating the probe effect on the system by systematically going through various
concentrations. 
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6 Discussion
 
6.5 Counter-ions in the self assembly of cationic lipids 
In the presence of a sufficient amount of NaCl the cationic gemini surfactant M-1 was found to
assemble into microscopic vesicles rather than forming micelles. Screening of the cationic charge
has been previously associated with the loss of interdigitation in DHAB vesicles (Ryhänen et al. 
2005). Cationic gemini surfactants have a relatively large effective head-group due to the two 
cationic charges at the opposing ends of the molecules. Electrostatic repulsion between these tends 
to expand the molecule, thus favoring the formation of micellar structures. A possible reasoning 
for the observed transition into low curvature giant vesicles with bilayer structure is the effective
screening of the cationic charges by the chloride counter-ions. This leads to a dramatic change in 
the molecular shape since the charges that are responsible for the effective size are screened, thus
allowing for tighter packing of the molecules. The fixed distance of the two cationic charges on the 
gemini surfactant also provide a nucleation center for the Cl--ions followed by an adjacent layer of 
Na+-ions forming a commensurate pseudocrystalline counter-ion lattice. Such a lattice is planar in
shape and thus further favors the formation of GVs as compare to membrane vesicles with larger
absolute curvature. 
Temperature and ionic strength induced changes in the self assembly of liposomes are especially
interesting as such factors could be relatively easily modified in tissues for example when targeting 
nanoparticles for e.g. drug delivery to tumors. Such applications could involve the use of focused
ultrasound to locally increase the temperature of the target and by such manipulation force the 
nanoparticle to release its cargo in a controlled manner. 
6.6 Conclusions 
To conclude lipid membranes are highly diverse cellular components with a number of parameters 
regulating cellular function as well as affecting drug binding and distribution in an organism. 
Understanding the role of phospholipid membranes in cells requires thorough biophysical
characterization of simple model systems in order to expand our view to more complex living
systems. In this thesis I address some of these properties with special focus on lipid phase behavior
and drug effects on membranes.
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6.6 Conclusions 

In the first part a fluorescence based method for determining the association of various
compounds to phospholipid membranes was developed. This method was employed in the 
original publication II where a small molecule drug compound was found to interact specifically 
with phosphatidic acid. This counters the original hypothesis of there being a non-specific
membrane disturbing effect of this drug underlying its observed apoptosis induction in cancer cell
lines. The interaction with PA offers an alternative interpretation of the anti-cancer action of the 
drug, namely disturbing the physiological function of PA as a growth promoting second
messenger. Further studies with structurally different compounds specifically designed to interact
with PA would be of great interest in furthering our understanding of lipid second messengers as
potential drug targets. 
In the original publications III and IV the self-assembly of lipids was addressed. In III the phase
behavior of a binary lipid mixture was studied with special focus on the effect of the lamellarity of 
the lipid vesicles. Inter-lamellar interactions have a strong influence on the behavior of the
commonly used membrane models LUVs and MLVs. This needs to be considered when 
interpreting future experiments using these models. Also the incorporation of a pyrene labeled 
lipid analog was found to affect the behavior of especially MLVs below Tm. 
In the final part (IV) cationic gemini surfactant vesicles reacted strongly to changes in the ionic 
strength of the solvent spontaneously forming giant vesicles. Such transitions, triggered by 
environmental changes are of interest in e.g. the design of functional nanoparticles aiming for
specific targets and being able to release their cargo in a controlled manner.
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